Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
CO-DIAGNOSTICS
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
March 25, 2026
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
March 20, 2026
Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast
March 17, 2026
Co-Diagnostics to Present at Medical Korea 2026
March 16, 2026
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
March 12, 2026
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements
March 10, 2026
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
February 8, 2026
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
February 5, 2026
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
January 12, 2026
Co-Diagnostics Announces Reverse Stock Split
December 30, 2025
←
Previous Page
1
2
3
Next Page
→